A Vella - Journal of Diabetes Science and Technology, 2009 - journalofdst.org There is a relative dearth of studies designed to elucidate genetic variation
that can explain differences in the response to diabetes pharmacotherapy. When
designing such studies, appropriate consideration of the various nongenetic ... Cited by 1 - Related articles - View as HTML - All 2 versions
JC Florez - Journal of Diabetes Science and Technology, 2009 - journalofdst.org Since 2000, we have witnessed an explosion of known genetic determinants of type
2 diabetes risk. These findings have seeded the expectation that our ability to
make personalized, predictive, therapeutic clinical decisions is imminent. ... Cited by 1 - Related articles - View as HTML - All 2 versions
MK Degorter, RB Kim - Hepatology (Baltimore, Md.), 2009 - ncbi.nlm.nih.gov 1: Hepatology. 2009 Aug 10;50(4):1014-1016. [Epub ahead of print]. Hepatic
drug transporters, old and new: Pharmacogenomics, drug ... Related articles - All 2 versions
[CITATION] Hepatic drug transporters, old and new: Pharmacogenomics, drug response, and clinical …
MK DeGorter, RB Kim - Hepatology, 2009 - Wiley Subscription Services, Inc., A Wiley Company … Related articles
F Giorgino, P Gentili, T Bufacchi, N Visalli, M … - G It Diabetol Metab, 2009 - gidm.it Si discute da tempo su quale possa essere l'approccio tera- peutico più
corretto nei confronti del paziente con diabete di tipo 2 di recente insorgenza.
Certamente, l'approccio globa- le prevede che venga posta attenzione a vari ... Related articles - View as HTML - All 2 versions